Press Release
July 26, 2023
Kincell Bio Launches
Cell therapy CDMO spins out of Inceptor Bio to help innovators develop and manufacture life-saving cell therapies RALEIGH, N.C., AND…
Kineticos believes the $40+ billion outsourced market will continue to expand with a growing number of therapeutic companies seeking services. This comes at a time of a service disconnect; for example, in cell and gene therapy – a Kineticos’ area of investment – there is simply not enough capacity and poor service offerings.
Kineticos works with companies at all stages of their life cycle, from start-up to commercialization.
Cell therapy CDMO spins out of Inceptor Bio to help innovators develop and manufacture life-saving cell therapies RALEIGH, N.C., AND…
Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, today announced the…
Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announced the acquisition of Arranta Bio.